From April 1, 2024 to June 30, 2024, the company has repurchased 1,354,900 shares, representing 1.73% for CNY 32.11 million. With this, the company has completed the repurchase of 4,036,458 shares, representing 5.05% for CNY 93.42 million under the buyback announced on February 29, 2024.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
Equities
301130
CNE1000058C4
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.1 CNY | -0.04% |
|
-0.26% | -17.14% |
1st Jan change | Capi. | |
---|---|---|
-17.14% | 25Cr | |
+63.13% | 86TCr | |
+38.95% | 63TCr | |
-4.15% | 36TCr | |
+17.63% | 32TCr | |
+8.78% | 30TCr | |
+6.05% | 23TCr | |
+16.57% | 23TCr | |
+15.67% | 18TCr | |
+2.17% | 16TCr |
- Stock Market
- Equities
- 301130 Stock
- News Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
- Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024.